Heating is a multifunctional adjuvant that affects tumor microenvironment through several intrinsic and extrinsic mechanisms, which could enhance immunotherapy.

Slides:



Advertisements
Similar presentations
Innate immunity is germline encode (you are born with it ready to go) It has made the self/nonself discrimination on an evolutionary time-scale It uses.
Advertisements

Cell-Mediated Effector Responses Chapter 14
Lymphocyte development and survival Chapter 7. Objectives Describe or construct flow charts showing the stages in development of B cells and T cells,
T cell-mediated immunity Chapter 8
Cell Mediated Immunity (CMI) Prof. Dr. Zahid Shakoor MBBS, Ph D (London) College of Medicine King Saud University.
Host Defense Against Tumors (Tumor Immunity)
Interferon-γ (IFNγ), a cytokine secreted by effector lymphocytes upon activation, is known to cause upregulation of MHC class I in tumor cells, which has.
HOST DEFENCE AGAINST TUMORS:
Lecture 16 Cellular Cooperation and Antigen Recognition
Chapter 43 The Immune System.
David P. Carbone, MD, PhD, David R. Gandara, MD, Scott J
Figure Legend: From: Immune Modulation by Volatile Anesthetics
Cellular Immune response
Thymocyte development summary
Mononuclear phagocytes in Immune Defence
CELL-MEDIATED IMMUNITY RAHUL KUMAR LOHANA 2K16/MB/50 INSTITUTE OF MICROBIOLOGY UNIVERSITY OF SINDH, JAMSHORO.
Avoiding Immune Detection
Figure 1 CTLA-4 and PD-1–PD-L1 immune checkpoints
Immunotherapy of hepatocellular carcinoma
Inducing Angiogenesis
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 2 Immune-escape mechanisms of CTCs in the peripheral blood
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Four nodes to target when inducing anti-tumour immunity
T cell mediated immunity
Immunology Cell Volume 100, Issue 1, Pages (January 2000)
The role of viruses in acute exacerbations of asthma
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Antigen-induced regulatory T cells
Megan E. Daly, MD, Arta M. Monjazeb, MD, PhD, Karen Kelly, MD 
David P. Carbone, MD, PhD, David R. Gandara, MD, Scott J
Malaria Vaccine Design: Immunological Considerations
Colorectal cancer vaccines: Principles, results, and perspectives
Figure 2 Emerging models of antibody-mediated rejection (ABMR) and
Nat. Rev. Nephrol. doi: /nrneph
Robert J Korst, MD, Ronald G Crystal, MD 
Mechanisms of immune escape in the tumor microenvironment.
Fig. 3. Tumor hypoxia and acidosis promote immunosuppression.
Vascular HR ligand expression depends on tumor anatomical location.
Mechanism of CTLA-4-induced immunosuppression.
Nat. Rev. Endocrinol. doi: /nrendo
Dendritic cells: regulators of hepatic immunity or tolerance?
The Tim-3 pathway in cancer.
Schematic representation of mechanisms leading to the synergy of anti-CD137 and anti–PD-1 immunostimulatory mAbs. Schematic representation of mechanisms.
Figure 1 Mechanisms of action of immunotherapy modalities
Tumor-Associated Macrophages: From Mechanisms to Therapy
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Nat. Rev. Urol. doi: /nrurol
Deciphering and Reversing Tumor Immune Suppression
Endothelial Cells Form a Phalanx to Block Tumor Metastasis
Figure 2 Immune changes in peripheral blood of pregnant patients with NMO Immune changes in peripheral blood of pregnant patients with NMO (A) Interleukin.
Cell-mediated immunity Regulation of the immune response
SPECIFIC IMMUNE RESPONSE
Volume 71, Issue 12, Pages (June 2007)
Mechanisms by which HRV increases susceptibility to bacterial infection. Mechanisms by which HRV increases susceptibility to bacterial infection. (1) HRVs.
Mechanism of PD-1/PD-L1 pathway-induced immunosuppression within the tumour microenvironment. Mechanism of PD-1/PD-L1 pathway-induced immunosuppression.
Distribution of immune checkpoint in tumor cells and immune microenvironment. CTLA-4, cytotoxic T lymphocyte antigen-4; MHC, major histocompatibility complex;
IgA nephropathy: markers of progression and clues to pathogenesis
Dendritic-Cell-Based Therapeutic Cancer Vaccines
TSLP and Th2 Cells TSLP TSLP TSLP
Influence of the tumor microenvironment on FL
General overview of innate and adaptive immune responses to and regulation of black yeasts. General overview of innate and adaptive immune responses to.
Advances and highlights in mechanisms of allergic disease in 2015
Human cancer immunotherapy strategies targeting B7-H3 A, blockade of B7-H3 with blocking mAbs neutralizes inhibitory signaling in its unidentified receptor(s)
CTLA-4 and PD-1 modulate different aspects of the T-cell response: A, CTLA-4 is upregulated after antigen-specific activation of a naïve or memory T cell.
Combination of R848 and anti-CD200R affects activation of tumor-infiltrating myeloid cells. Combination of R848 and anti-CD200R affects activation of tumor-infiltrating.
Cytokines and cytokine receptors involved in type I immunity in tuberculosis. Cytokines and cytokine receptors involved in type I immunity in tuberculosis.
Something in the Air: Hyperoxic Conditioning of the Tumor Microenvironment for Enhanced Immunotherapy  Robert D. Leone, Maureen R. Horton, Jonathan D.
Phenotyping of T cells. Phenotyping of T cells. Circulating lymphocytes from a tumor-naïve C57BL/6 mice (left column) were compared with those from C57BL/6.
Presentation transcript:

Heating is a multifunctional adjuvant that affects tumor microenvironment through several intrinsic and extrinsic mechanisms, which could enhance immunotherapy in the following ways: increasing vascular perfusion and blood flow to the tumor occurring throug... Heating is a multifunctional adjuvant that affects tumor microenvironment through several intrinsic and extrinsic mechanisms, which could enhance immunotherapy in the following ways: increasing vascular perfusion and blood flow to the tumor occurring through both thermoregulatory signals, as well as changes in tumor metabolism, leading to increased hypoxia-inducible factor-1 (HIF-1), which leads to increased reactive oxygen species (ROS) production and VEGF expression; increased trafficking of CD8+ T cells occurring through heat-induced increases in E/P selectin and intercellular adhesion molecule 1 (ICAM-1) on tumor blood vessels; increased T-cell receptor (TCR) signaling and differentiation of naïve T cells to effector cells; increased tumor cell-surface expression of MHC class I ligand (MICA/B) and upregulation of the ligand NKG2D on natural killer (NK) cells, increasing NK cell cytotoxic potential; increased functional activity of macrophages and dendritic cells; and increased release of HSPs into the extracellular environment, stimulating downstream immune activity, and increasing antigen presentation. IL, interleukin. Elizabeth A. Repasky et al. Cancer Immunol Res 2013;1:210-216 ©2013 by American Association for Cancer Research